Marinus Pharmaceuticals (MRNS) Financials

$0.55

$0.00 (0.00%)

As on 11-Feb-2025 09:30EDT

Market cap

$30 Mln

Revenue (TTM)

$31 Mln

P/E Ratio

--

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	31.47	30.99	25.48	15.35	1.72	--
Cost of Revenue	3.49	1.93	0.34	1.48	50.51	0.50
Gross Profit	27.98	29.06	25.14	13.87	1.72	-0.50
Operating Expenses	150.74	160.54	137.93	110.80	69.66	54.42
Operating Profit (EBIT)	-124.57	-131.49	-112.79	-96.93	-67.94	-54.42
Other Income	--	--	-0.34	0.08	0.46	0.30
Profit before Tax	-140.49	-142.94	-16.43	-98.78	-67.48	-54.12
Provision for Tax	3.46	-1.54	3.39	2.88	-0.83	-0.35
Profit after Tax (Net Income)	-140.49	-141.41	-19.82	-101.66	-66.64	-53.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-19.82	-98.78	-76.36	-54.12

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-66.74	16.77	116.00	53.49	137.20	87.77
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	95.86	113.52	88.64	42.79	2.53	3.04
Current Liabilities	34.50	40.62	54.87	40.57	10.73	8.03
Total Liabilities	98.13	170.91	259.52	136.84	150.46	98.84

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	6.22	5.66	18.97	13.91	10.31	4.71
Current Assets	57.40	165.25	240.55	122.93	140.16	94.13
Total Assets	98.13	170.91	259.52	136.84	150.46	98.84
Total Debt*	55.99	110.36	72.68	41.37	0.51	0.45
Net Current Assets	22.90	124.62	185.68	82.36	135.54	86.10

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-118.00	-112.89	-55.48	-60.91	-48.63
Cash Flow from Investing Activities	--	--	105.77	-1.42	-0.74	3.88
Cash from Financing Activities	--	26.63	124.74	41.31	109.22	67.97
Net Cash Inflow / Outflow	--	--	117.62	-15.58	47.57	23.22

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-2.47	-2.49	-0.44	-2.77	-2.09	-2.48
Cash EPS ($)	--	-2.49	-0.43	-2.76	-2.08	-2.47
Adjusted Book Value ($)	--	0.30	2.58	1.46	4.31	4.05
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.08	-2.51	-1.51	-1.91	-2.24
Free Cash Flow per Share ($)	--	-2.08	-2.55	-1.59	-1.91	-2.26

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-89.55	-13.98	-87.43	-59.00	-68.69
ROE (%)	--	-213.02	-23.38	-106.63	-59.25	-68.89
ROA (%)	-85.28	-65.70	-10.00	-70.77	-53.46	-61.77
EBIT Margin (%)	-394.77	-406.75	-22.59	-626.88	-3,954.42	--
Net Margin (%)	-446.49	-456.31	-78.84	-659.06	-3,056.97	-17,862.79
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	1.63	0.22	0.66	7.93	--	--
EBIT Growth (%)	-2.82	-2,090.23	94.02	-41.59	-25.08	-47.76
Net Profit Growth (%)	-5.01	-613.59	80.51	-52.55	-23.95	-46.40
EPS Growth (%)	6.86	-4.66	0.84	-0.32	0.16	0.11
Book Value Growth (%)	-215.30	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-4.36	-9.03	-4.29	-5.83	-0.87
Price / Book Value	3.17	36.76	1.54	8.16	2.83	0.53
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-34.47	-4.59	-2.19	-3.72	-3.68	0.82
Close Price ($)	1.76	10.87	3.98	11.88	12.20	8.64
High Price ($)	11.26	11.25	13.15	20.04	17.14	21.60
Low Price ($)	1.05	3.56	3.47	9.10	4.16	3.08
Market Cap ($ Cr)	30.37	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	-0.63	6.58	0.63	0.77	0.00	0.01
Short term debt to equity ratio	-0.21	0.87	0.01	0.01	0.00	0.01
Current Ratio	1.66	4.07	4.38	3.03	13.06	11.72
Quick Ratio	1.47	4.01	4.38	3.26	13.65	--
Interest Coverage	-7.21	-7.46	-0.54	-37.26	-136.15	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	12.20	12.26	24.92	20.76	95.81	--
Asset Turnover	0.19	0.14	0.13	0.11	0.01	--
Receivable days	--	59.80	68.34	57.51	349.94	--
Inventory Days	--	235.13	-4,958.27	-1,926.58	-45.44	--
Payable days	--	799.24	4,075.22	659.45	17.99	1,900.68
Cash Conversion Cycle	--	-504.32	-8,965.15	-2,528.53	286.51	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.